Skip to content
Homepage
Author:
Optimum Strategic Communications
Posted Date:
January 27, 2026
Resolve M Therapeutics exits from stealth
Optimum Strategic Communications
January 27, 2026
New Global Consortium Aims to Transform Antibiotic Discovery to Counter the Growing AMR Crisis
Optimum Strategic Communications
January 27, 2026
Women in Life Science Denmark (WiLD) expands Nordic footprint with launch of WiLD Finland
Optimum Strategic Communications
January 26, 2026
Infinitopes Expands Seed Financing to $35 Million to Accelerate Clinical Development of Precision Cancer Vaccine
Optimum Strategic Communications
January 26, 2026
